| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 0.0002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.24 | 3e-09 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |